Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000468241 | SCV000560007 | benign | Gorlin syndrome | 2024-06-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001755715 | SCV002005568 | likely benign | not provided | 2020-12-18 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002475914 | SCV002798589 | likely benign | Basal cell carcinoma, susceptibility to, 1; Gorlin syndrome; Medulloblastoma | 2021-11-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001755715 | SCV005434833 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | PTCH2: BP4, BS1 |